WARF Startup Portfolio Stats
WARF holds equity in more than 30 of these companies, and more than 50 are located in Wisconsin. Some of these companies have achieved IPO status as publicly traded companies and have been acquired by large, well-established companies, such as Roche, Johnson & Johnson and Hologic.
Antibiotic-free strategy to promote natural immune functioning in animal agriculture
Innovative detection reagents and technologies
Artificial intelligence to evaluate treatment response in complex diseases.
Innovative cancer drug development
Stem cell research tools
Self-serve kiosk design and services for people with sensory or mobility impairment.
Therapies based on pluripotent stem cells
Device to improve atrial arrhythmia diagnosis.
Provide innovative and optimization tools for researchers around the world.
Rapid, sensitive tests for the detection of botulinum neurotoxins (BoNT)
Highly enriched neuronal and glial cells
Flushing and cold-storage solutions for organ transplants of the liver, kidney and pancreas
The world's lightest, most powerful non-rare earth electric motors and non-contact power transfer devices
MRI phantoms for quantitative imaging
Cardiovascular cell therapy.
Precision therapies for advanced forms of cancer
Ongoing mobile support and relapse prevention for people recovering from alcohol-use disorders
Innovative cancer drug development.
Mesenchymal stem cells (MSCs) for therapeutic use
Conversational intelligence platform.
Therapy development for degenerative disorders caused by nucleotide repeat expansions.
Mineral Coated Microparticle technology treatment targeting autoimmune diseases.
Developing sitruin drugs
Economical biomass conversion
Artificial intelligence and machine learning for data management.
Screening and determination of the aggressiveness of prostate cancer.
Metal microfabricated products
Gene therapy for pediatric patients with a retinal blinding disease.
Software that aids healthcare organizations in reducing costs, increasing efficiency and reducing physicians' workload
Quantum Cascade Laser (QCL) technologies
Understanding the immune response through applies mathematics.
Breath-based biomarkers that provide an early, pre-symptomatic warning of a developing severe infection
Stand-up CT scanner and radiotherapy system that reduces the cost of radiotherapy and improves cancer patient outcomes through upright positioning
Therapeutic compounds that combine the targeting abilities of biologics with the stability of small molecules
Personalized cancer treatments to patients.
DNA vaccines intended to treat prostate cancer at crucial stages in the disease
More effective tools for liver surgery and localized cancer treatment by heat
High volume production microscale additive manufacturing platform
Custom monoclonal antibodies for research, diagnostics and therapeutics
Electrode platform for diagnostic and therapeutic neurological applications.
Piezo stages, nanopositioners and nanopositioning systems for nanoscale research and manufacturing
Hydrogel implant that delivers a combination chemotherapy for treating brain cancers
Medical device for precise fluorescence image-guided surgery.
Vaccines and diagnostics to fight animal and human infectious diseases
Innovative and standarized medical imaging products using phantom technology.
Cutting-edge femtosecond spectroscopy solutions
Production of natural food dyes from high-pigment beets
Micro-machined sensors and actuators for semiconductor, nanotechnology and other applications
Sensors for industrial hygiene, environmental monitoring and research and cell-based assay systems for life science research
Stem cell treatment for patients with advanced heart failure.
Globally accessible, non-invasive and precise diagnostic test for ovarian cancer.
High mass molecule spectrometry detector with 15-fold better resolution
Digestive health product.
Oil-based chemical out of corn cobs for the production of everyday materials such as nylon, paint and plastic.
Transform stem cells into insulin producing cells to cure diabetes.
New treatments with stem cell innovations
Microfluidic devices for improved sample preparation
Clean Genome® Multiple Deletion Series (MDS) E. coli
High-performance design analysis and next-generation topology optimization
Stem cell-based type 1 diabetes treatments
Safe, clean, affordable production of medical tracers and cancer treatment elements
Organosilicon compounds for energy storage devices, especially electrolytes for lithium-ion batteries
Composable compute platform which accelerates the abilities of artificial intelligence and machine-learning
Microplotter for printing materials for printed electronics and biological spotting Microfabrication technologies that replace conventional switches and connectors
Advanced biomaterials for stem cell discovery and therapy
Metabolomic technologies to understand cell biology in both health and disease
Improved drug delivery using collagen mimetic peptides
Medicines to reduce the serious side effects of cancer treatments
Innovative drugs, medical foods and other products that improve the quality of human lives using phytochemistry.
Developing manufacturing processes based on bonding and layer transfer.
Electrochemical water treatment
Predictive technology for radiopharmaceutical therapy
BrainPort® V100, an oral electronic vision aid for profoundly blind individuals
Crop productivity maximization technology.
Wispr Digital Otoscope reliably provides a clear view of the eardrum
Generation of high quality and quantity of neural cells from human stem cells.
Unconventional yeasts for production of second generation biofuel precursors from existing feedstocks
Reliable, rugged and efficient laser and electro-optical systems for defense and security applications
Fully functioning human cells in industrial quantities IPO preceded acquisition Acquired by Fujifilm in 2015
LEAP™ microscope for 3-D structure and composition analysis at the nanoscale Acquired by Ametek in 2010
Developing genetically modified lactic acid bacteria products specifically for the biofuels industry. Acquired by Lallemand in 2017
Gene expression profiling as it relates to the aging process Acquired by Nu Skin Enterprises Inc. in 2011
Innovative nucleic acid research reagents Acquired by Roche in 2008
Fast, minimally invasive and highly effective soft tissue ablation system Acquired by Ethicon in 2016
DNA microarrays, consumables and instruments Acquired by Roche in 2007
Soft Switching Technologies
Protection against voltage sags and momentary outages Acquired by Rockwell Automation in 2012
Skin regeneration and repair products for therapeutic use Acquired by Mallinckrodt Pharmaceuticals in 2016
Molecular diagnostics for DNA and RNA analysis applications Acquired by Hologic in 2008
Skeletal reconstruction and bone regeneration technology
Precise cancer treatment system IPO preceded acquisition Acquired by Accuray in 2011
Platform that converts soluble biomass-derived sugars into gasoline, diesel and more Acquired by TESORO in 2016